⌘K

Login Start Free

Home/Filings/4/0000059478-25-000043

4//SEC Filing

Ricks David A 4

Accession 0000059478-25-000043

CIK 0000059478other

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 4:19 PM ET

Size

9.8 KB

Accession

0000059478-25-000043

Insider Transaction Report

Form 4

Period: 2025-02-10

ELI LILLY & CoLLY

SVP and Pres, Lilly Bio-Meds

Transactions

Award
Common Stock
2025-02-10$868.88/sh+55,131.56$47,902,710→ 539,613.167 total
Award
Restricted Stock Unit
2025-02-10+31,932→ 31,932 total
From: 2026-02-01Exp: 2026-02-01→ Common Stock (31,932 underlying)

Holdings

Common Stock
(indirect: By David A. Ricks SLAT)
68,656
Common Stock
(indirect: By Trust)
300
Common Stock
(indirect: By David A. Ricks 2022 GRAT)
59,457
Common Stock
(indirect: By 401(k))
7,264.97

Footnotes (2)

[F1]The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
[F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Documents

1 file

4
wk-form4_1739395137.xmlPrimary
FORM 4

Issuer

ELI LILLY & Co

CIK 0000059478

Entity typeother

Related Parties

1

filerCIK 0001538604

Filing Metadata

Form type: 4
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 4:19 PM ET
Size: 9.8 KB

View on SEC.gov